Arthur Fratamico

Arthur Fratamico

Direttore/Membro del Consiglio presso SUN BIOPHARMA INC
61 anni
Health Technology
Consumer Services

Profilo

Arthur J.
Fratamico
is currently an Independent Director at Panbela Therapeutics, Inc., a position held since 2019.
Formerly, Mr. Fratamico was President & Chief Executive Officer at Radiant Biotherapeutics, Inc., Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer at Flexion Therapeutics, Inc. from 2012 to 2014, Chief Business Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, Vice President-Business & Strategic Development at Gemin X Pharmaceuticals US, Inc. from 2009 to 2010, Principal at Hoechst Marion Roussel, Inc., Chief Business Officer at Trevena, Inc., and Chief Business Officer at Galera Therapeutics, Inc. Education includes an MBA from Drexel University and undergraduate studies at Philadelphia College of Pharmacy.

Posizioni attive di Arthur Fratamico

SocietàPosizioneInizio
SUN BIOPHARMA INC Direttore/Membro del Consiglio 16/12/2019

Precedenti posizioni note di Arthur Fratamico

SocietàPosizioneFine
VITAE PHARMACEUTICALS INC Corporate Officer/Principal 25/12/2016
FLEXION THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2014
Amministratore Delegato -
GALERA T COM USD0. Corporate Officer/Principal -
TREVENA, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Arthur Fratamico

Formazione di Arthur Fratamico

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

37

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Arthur Fratamico